Skip to main content

Accelerate Diagnostics Value Stock - Dividend - Research Selection

Accelerate Diagnostics

ISIN: US00430H1023, WKN: A1KA68

Market price date: 20.07.2021
Market price: 6,86 USD

Accelerate Diagnostics Fundamental data and company key figures of the share

Annual reports in USD
Key figures 16-06-2021
Cash flow
Net operating cash flow -50.394.000
Capital Expenditures -1.362.000
Free cash flow -51.756.000
Balance sheet
Total Equity -62.812.000
Liabilities & Shareholders equity 93.425.000
Income statement
Net income -78.208.000
Eps (diluted) -1,400
Diluted shares outstanding 57.607.900
Net sales/revenue 11.165.000

Fundamental ratios calculated on: 20-07-2021

Key figures 20-07-2021
Cash flow
P/C -7,84
P/FC -7,64
Balance sheet
Income statement
Div. Yield0,00%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization395.190.208,00 USD
IndicesNASDAQ Comp.
Raw Data SourceUS GAAP in Millionen USD
Stock Split2013-07-08,1231.000000/1230.000000; 1996-11-19,1.000000/4.000000

Description of the company

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. It offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms, as well as yeast. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is headquartered in Tucson, Arizona.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,